| 23 July 2012
The US Food and Drug Administration (FDA) approved two new drug entities for treating, respectively, certain forms of breast cancer and multiple myeloma on Friday, 20 July. The approvals capped off a Read More...
| 29 June 2012
The US Food and Drug Administration (FDA) issued a warning on Friday, 29 June regarding an implantable medical device manufactured by Covidien Plc subsidiary ev3’s Onyx Liquid Embolic System, which Read More...